MDM2 and well-differentiated liposarcoma: In one study (22), researchers compared the performance of MDM2 immunohistochemistry (IHC) in inflammatory well-differentiated liposarcoma (WDLS/ALT) with that in fibroinflammatory diseases (such as sclerosing mesenteritis and idiopathic retroperitoneal fibrosis).